HEPATITIS B
Clinical trials for HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B trials appear
Sign up with your email to follow new studies for HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers test extended dosing of hepatitis b drug
Disease control TerminatedThis study tested giving nine additional doses of an experimental drug called ARC-520 to people with chronic hepatitis B who had previously responded well to it. All 12 participants continued taking their standard daily hepatitis B medication alongside the ARC-520 injections. The…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental hepatitis b treatment fails to advance
Disease control TerminatedThis study tested whether adding an experimental drug called ARC-520 to standard hepatitis B medications could better reduce signs of the virus in the blood. It involved 58 adults with a specific type of chronic hepatitis B who were already taking standard antiviral pills. The tr…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Experimental drug tested to control hepatitis b virus
Disease control TerminatedThis study tested an experimental drug called ARC-520, given alone or with other standard hepatitis B medications, in people with chronic hepatitis B infection. The main goal was to see if the treatment could safely and significantly reduce the amount of hepatitis B virus in the …
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New shot at beating hepatitis b? experimental drug trial seeks to lower virus levels
Disease control TerminatedThis study tested whether adding an experimental drug called ARC-520 to standard hepatitis B medications could better reduce the amount of virus in the body. About 32 adults with a specific type of chronic hepatitis B received either ARC-520 or a placebo injection alongside their…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Halted trial tests new shot against silent liver virus
Disease control TerminatedThis was an early-stage study to test the safety and effects of a new drug called ARC-521 for people with chronic Hepatitis B. It involved 47 healthy volunteers and patients to see how their bodies handled different doses and if the drug could reduce the virus. The main goal was …
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC
-
Massive study tracks 1,700 hepatitis b patients to map disease journey
Knowledge-focused TerminatedThis study observed 1,708 adults with chronic hepatitis B across US and Canadian clinics to understand how the disease progresses and how treatments work in real-world settings. Researchers collected information about patients' treatments, health outcomes, and side effects withou…
Matched conditions: HEPATITIS B
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC